Imperial College London


Central FacultyOffice of the Provost

Associate Provost (Academic Partnerships)



+44 (0)20 7594 5406m.dallman Website




Ms Emelia Gobbe +44 (0)20 7594 7460




2.11Faculty BuildingSouth Kensington Campus





Professor Maggie Dallman, OBE, is Associate Provost (Academic Partnerships) and Professor of Immunology. In her Associate Provost role, Maggie is the academic lead on the College's Outreach Strategy and International relations. For further information view:

Maggie is also Chair of the college's Animal Welfare and Ethical Review Body.

Maggie joined Imperial College in 1994 as a lecturer in the Department of Biology, coming from the University of Oxford where she had held a Nuffield Medical Research Foundation Junior Research Fellowship followed by an MRC Senior Research Fellowship. At Imperial College she became Reader in Immunoregulation in 1996 and Professor of Immunology in 1999. Since 2001 Maggie has held increasingly senior positions at Imperial College including Head Section Immunology and Infection, Campus Dean and Deputy Principal for the Faculty of Natural Sciences, becoming Dean in 2008. Maggie took up her most recent role as Associate Provost (Academic Partnerships) on January 1st 2015.

Maggie participates in a broad range of external activities. She is currently a Director and Trustee of the Francis Crick Institute, sits on BBSRC Council and is Deputy Chair of the Scar Free Foundation Research Council.

Research Interests: An ability to generate immune responses to invading pathogens is vital to our well being and survival yet over-vigorous or inappropriate responses can lead to debilitating or life threatening conditions such as autoimmunity (e.g. diabetes, rheumatoid arthritis) and allergy. Further, as our understanding of disease develops we find that dysregulated inflammatory responses are associated with conditions as diverse as alzheimer’s disease and obesity. An understanding of and an ability to control inappropriate immunity and inflammation lie therefore on the path to successful treatment of these varied diseases. Maggie’s own work uses a range of organisms from zebrafish (ZFIN webpage) to humans to study at the molecular, cellular and whole individual level not only the basis for disease but also potential approaches to therapy.

View the Dallman Lab website for further information.



Andrews N, Ramel M-C, Kumar S, et al., 2016, Visualising apoptosis in live zebrafish using fluorescence lifetime imaging with optical projection tomography to map FRET biosensor activity in space and time, Journal of Biophotonics, Vol:9, ISSN:1864-063X, Pages:414-424

Kumar S, Lockwood N, Ramel M-C, et al., 2016, Quantitative in vivo optical tomography of cancer progression & vasculature development in adult zebrafish, Oncotarget, Vol:7, ISSN:1949-2553, Pages:43939-43948

Progatzky F, Cook HT, Lamb JR, et al., 2016, Mucosal inflammation at the respiratory interface: a zebrafish model, American Journal of Physiology-lung Cellular and Molecular Physiology, Vol:310, ISSN:1040-0605, Pages:L551-L561

Broncel M, Serwa RA, Ciepla P, et al., 2015, Multifunctional Reagents for Quantitative Proteome-Wide Analysis of Protein Modification in Human Cells and Dynamic Profiling of Protein Lipidation During Vertebrate Development, Angewandte Chemie-international Edition, Vol:54, ISSN:1433-7851, Pages:5948-5951


Jha A, Progatzky F, Wane M, et al., 2016, Human nasal mucosal responses to TLR agonists are mirrored by the zebrafish gill, British Association of Lung Research Summer Congress

More Publications